Cartesian Therapeutics, Inc.

Historical 13F Holders

Symbol
RNAC
CUSIP
816212302
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 816212302 since 12/18/2024, newest first.

Filer % of Class Filed
Barclays PLC 13G 6.0% 8/13/2026
Event 6/30/2026
JPMorgan Chase & Co 13G/A Amendment 1 4.8% 7/22/2026
Event 6/30/2026
FMR LLC 13G/A Amendment 4
3.0% 5/6/2026
Event 3/31/2026
Squarepoint Ops LLC 13G
8.3% 3/13/2026
Event 3/9/2026
FMR LLC 13G/A Amendment 3
5.3% 2/5/2026
Event 12/31/2025
FMR LLC 13G/A Amendment 2
8.3% 11/5/2025
Event 9/30/2025
JPMorgan Chase & Co 13G 6.1% 4/25/2025
Event 3/31/2025
FMR LLC 13G/A Amendment 1
9.4% 2/12/2025
Event 12/31/2024
Timothy A. Springer 13D/A Amendment 19
36.9% 1/15/2025
Event 1/13/2025
Timothy A. Springer 13D/A Amendment 18
36.8% 12/23/2024
Event 12/19/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 1.07 k $7.70 k
2026 Q2 100 8.69 M $90.5 M
2026 Q1 84 7.15 M $43.9 M
2025 Q4 71 5.16 M $37.2 M
2025 Q3 72 6.00 M $61.0 M
2025 Q2 70 6.42 M $66.7 M
2025 Q1 73 6.58 M $86.7 M
2024 Q4 69 6.67 M $119 M
2024 Q3 66 7.18 M $115 M
2024 Q2 67 3.68 M $99.2 M
2024 Q1 4 1.86 k $1.16 k
2023 Q3 1 1.20 k $1.27 k
2023 Q2 1 1.20 k $1.34 k
2023 Q1 1 1.20 k $1.67 k